Shovanlal Gayen Selected Research

Phosphotransferases (Kinase)

1/2022

How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shovanlal Gayen Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 12/2003
7	COVID-19 02/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 11/2022 - 10/2018
2	Severe Acute Respiratory Syndrome 08/2021 - 01/2020
2	Malaria 01/2020 - 05/2011
2	Atherosclerosis 01/2019 - 02/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 10/2006
1	Shock 01/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2023
1	Toxic Optic Neuropathy 06/2023
1	Carcinoma (Carcinomatosis) 01/2022
1	Trypanosomiasis 01/2020
1	Common Cold 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Leishmaniasis 01/2020
1	Obesity 01/2019
1	Insulin Resistance 01/2019
1	Rheumatoid Arthritis 02/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2018
1	Asthma (Bronchial Asthma) 02/2018
1	Multiple Sclerosis 02/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Retinal Neovascularization 11/2017
1	Huntington Disease (Huntington's Disease) 12/2016
1	Dengue (Dengue Fever) 05/2013

Drug/Important Bio-Agent (IBA)

9	Peptide Hydrolases (Proteases)FDA Link 11/2022 - 05/2013
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2004
3	EnzymesIBA 10/2023 - 04/2020
3	PapainIBA 02/2022 - 01/2021
1	Histone Deacetylase InhibitorsIBA 04/2024
1	Viral ProteinsIBA 01/2024
1	PCI 34051IBA 10/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2023
1	CationsIBA 06/2023
1	Sulfanilamide FDA Link 06/2023
1	Topiramate (Topamax)FDA LinkGeneric 06/2023
1	Bortezomib (Velcade)FDA Link 06/2023
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 06/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2023
1	tosufloxacinIBA 06/2023
1	Choline KinaseIBA 12/2022
1	Lysine (L-Lysine)FDA Link 12/2022
1	Protein Kinases (Protein Kinase)IBA 12/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2022
1	Aurora KinasesIBA 12/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022
1	TankyrasesIBA 12/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2022
1	multidrug resistance-associated protein 1IBA 11/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	MicrocystinsIBA 01/2022
1	Coronavirus Protease InhibitorsIBA 08/2021
1	LigandsIBA 05/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2021
1	Chalcone (Benzalacetophenone)IBA 01/2020
1	Chemokine ReceptorsIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	2-phenylindoleIBA 10/2018
1	IntegrinsIBA 02/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	IndolesIBA 11/2017
1	Angiogenesis InhibitorsIBA 11/2017
1	Huntingtin ProteinIBA 12/2016
1	KynurenineIBA 12/2016
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2016
1	Tumor Suppressor Protein p53IBA 01/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2006
1	AmidesIBA 03/2004
1	Glutamine (L-Glutamine)FDA Link 03/2004
1	purineIBA 03/2004
1	NitrogenIBA 03/2004
1	Glutamic Acid (Glutamate)FDA Link 03/2004
1	Essential Amino AcidsIBA 03/2004
1	Nucleic AcidsIBA 03/2004
1	pyrimidineIBA 03/2004
1	Antineoplastic Agents (Antineoplastics)IBA 12/2003
1	pyridoacridineIBA 12/2003
1	HydrogenIBA 12/2003
1	ascidideminIBA 12/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2022
1	Immunotherapy 04/2020